德展健康

000813 SZSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

7.1B ($1.0B)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

466.0M

Net Income

-42.2M

Gross Margin

N/A

Op. Margin

-9.1%

Net Margin

-9.1%

ROE

-0.8%

ROA

-0.8%

D/E

0.03

Dividend Yield

N/A

EPS

-0.01

Current Ratio

30.46

Price History

Company Info

Industry	C27医药制造业
Market Segment	Main Board
Currency	CNY
Fiscal Year	2024

Business Overview

Dezhan Healthcare Company Limited engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People's Republic of China. The company offers atorvastatin calcium tablets, amlodipine atorvastatin calcium tablets, trimetazidine hydrochloride capsules, amiodarone hydrochloride tablets, as well as other drugs, including famciclovir tablets, azathioprine tablets, and hydroxyurea tablets and colchicine tablet. It also involved in the provision of biological peptides, industrial hemp, and medical service business. The company was founded in 1980 a...

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 德展健康

Ticker	000813
Exchange	SZSE
Sector	证监会行业分类
Industry	C27医药制造业